Drug: ARIPIPRAZOLE. Injury: Salivary hypersecretion Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125032192 | ARIPIPRAZOLE. | Salivary hypersecretion | ACCORD | 26.00 YR | M | 0 | 20160726 | PL |
| 125899541 | ARIPIPRAZOLE. | Salivary hypersecretion | TEVA | 26.00 YR | M | 0 | 20160725 | PL |
| 125902441 | ARIPIPRAZOLE. | Salivary hypersecretion | ABBVIE | 26.00 YR | M | 0 | 20160725 | COUNTRY NOT SPECIFIED |
| 126223951 | ARIPIPRAZOLE. | Salivary hypersecretion | ALKEM | 26.00 YR | M | 0 | 20160804 | PL |
| 126281541 | ARIPIPRAZOLE. | Salivary hypersecretion | APOTEX | 26.00 YR | M | 0 | 20160808 | PL |
| 126603991 | ARIPIPRAZOLE. | Salivary hypersecretion | MYLAN | 0.00 | 0 | 20160817 | JP | |
| 822194512 | ARIPIPRAZOLE. | Salivary hypersecretion | SANDOZ | 19.22 YR | F | 52 KG | 20160815 | JP |
Total Records: 7 Number of Pages: 1